Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Quick Stats
Jan 30, 202639.5
AI Score
SELL1.21
Volume Ratio
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
PALI Stock Summary
Last updated Jan 30, 2026
PALI is currently trading at $1.49, positioned above its 200-day moving average of $1.24, indicating a long-term uptrend. The stock has a 52-week range of $0.53 to $2.64.
Technical Analysis: The 50-day moving average stands at $1.97, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.279, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.14, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PALI at 39.5/100 with a SELL recommendation.
PALI (Palisade Bio, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.279 |
| CMF (20) | -0.14 |
| ROC (10) | -14.857 |
| ADX (14) | 11.899 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.099 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -92.857 |
| MFI (14) | 35.003 |
PALI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PALI Price vs Max Options Open Interest
PALI Max Change In Options Open Interest
PALI Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PALI Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PALI Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PALI Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Palisade Bio, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
PALI Moving Averages Analysis
Palisade Bio, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
PALI (Palisade Bio, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.75 |
| 20 | 1.87 |
| 30 | 1.94 |
| 50 | 1.97 |
| 100 | 1.71 |
| 200 | 1.24 |
PALI Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 249.2 million |
| Earnings/Share ($) | -2.07 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.534 |
| EPS Estimate Next Year ($) | -0.23 |
| WallStreet Target Price ($) | 13.4 |
| Most Recent Quarter |